| Today's Open | $44.94 |
|---|---|
| Previous Close | $45.01 |
| Daily Range | $44.83 - $45.28 |
| 52-Week Range | $31.48 - $46.90 |
| Market Cap | $2.2B |
| P/E Ratio | 21.54 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 108,510 |
| Average Daily Volume | 507,387 |
| Current FY EPS | $2.81 |
Sector
Healthcare
Industry
Drugs
Charles River Laboratories (CRL) Description
Charles River supports early-stage drug development with a “research models” business that breeds lab rats and “preclinical services” that run clinical trials for pharma and biotech companies. Website: http://www.criver.com/
News & Commentary
The Danger of Chasing This IPO's Profits
The largest contract research organization is back on the marketCharles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call Transc
Charles River Laboratories International Management Discusses Q1 2013 Results - Earnings Call TranscriptCRL's Top Competitors
(-0.07%)
(2.17%)
(0.05%)
(-0.12%)